Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rory Barry (Autor), Gregg Murray (Autor), Sally McGrath (Autor), Clive Kilgallen (Autor), Karen Eustace (Autor)
Format: Knjiga
Izdano: Wiley, 2024-09-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno